Status:
APPROVED_FOR_MARKETING
Compassionate Use of Pozelimab
Lead Sponsor:
Regeneron Pharmaceuticals
Conditions:
CD55-deficient Protein-losing Enteropathy
Brief Summary
Provide compassionate use of pozelimab
Detailed Description
Compassionate Use requests are only being considered in response to Individual Patient Investigational New Drug (IND) applications.
Eligibility Criteria
Inclusion
- \-
Exclusion
- \-
Key Trial Info
Start Date :
Trial Type :
EXPANDED_ACCESS
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT05232110
Last Update
November 7 2025
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.